View Document Preview and Link Document Date: 2012-04-18 11:56:04 Open Document File Size: 320,06 KB Share Result on Facebook
City Redwood City / Atlanta / Lille / New York / Nantes / Gloucester / St. Louis / / Company Facet Biotech / Novartis 2 Elotuzumab / Bristol Bristol-Myers Myers Squibb Company Company / Gloucester Pharmaceuticals / Bristol-Myers Squibb Company / Celgene Corporation Corporation / Millennium Pharmaceuticals / Novartis Research Funding / / Country France / United States / / Currency pence / / Event FDA Phase / / Facility Vincent's Comprehensive Cancer Center / University Hospital / The Winship Cancer Institute / University School / / MedicalCondition headache flushing headache / Measurable disease / Multiple Myeloma / flushing / disease / chills / Neutropenia Muscle spasms Pyrexia Insomnia Back pain / Relapsed Refractory Multiple Myeloma / vomiting / plasmacytomas / stridor Arthralgia Asthenia Headache Thrombocytopenia / stable disease / hypersensitivity / Hypokalemia / nausea nausea / / MedicalTreatment premedication / / MusicGroup Nausea / / Organization Vincent's Comprehensive Cancer Center / 3Washington University School of Medicine / 2Emory University School of Medicine / University Hospital / Winship Cancer Institute / 6Hematology Department / / Person René Gauducheau / / Position Consultant / / Product Dexamethasone / receiving study drug / Model1 / / ProvinceOrState South Dakota / New York / / Technology pharmacokinetics / hybridization / / SocialTag 
Microsoft PowerPoint - BMS10613_1703ASCOOral_Final_v3 [Compatibility Mode]